The Genomic Atlas of Breast Cancer — the non-coding theme

Update News

  • GABC update 2020.06.15
  • GABC update 2019.03.20
  • GABC online 2018.08.09
  • Data collection 2018.04.09

About Us

  • Steven Xi Chen:
    steven.chen@miami.edu
  • Yunpeng Zhang:
    YXZ1418@med.miami.edu
  • Peng Wang:
    wpgqy@163.com
  • Shangwei Ning:
    ningsw@ems.hrbmu.edu.cn
  • Xia Li:
    lixia@hrbmu.edu.cn

Detail


Chr chr11
start 1995176
end 2001470
lncRNA name H19
entrez id 283120
hgnc id HGNC:4713
ensg id ENSG00000130600
refseq id NR_002196
methods qPCR, RNAi, Luciferase reporter assay, ISH etc.
regulated up-regulated
function description BCSCs express high levels of H19, and ectopic overexpression of H19 significantly promotes breast cancer cell clonogenicity, migration and mammosphere-forming ability. Conversely, silencing of H19 represses these BCSC properties. In concordance, knockdown of H19 markedly inhibits tumor growth and suppresses tumorigenesis in nude mice. Mechanistically, we found that H19 functions as a competing endogenous RNA to sponge miRNA let-7, leading to an increase in expression of a let-7 target, the core pluripotency factor LIN28, which is enriched in BCSC populations and breast patient samples.
pubmed id 28102845
year 2017
title H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance.
drug X
circulating X
survival V

CopyRight © University of Miami, USA; Harbin Medical University, China